Ameritas Investment Partners’s Outset Medical OM Stock Holding History

Ameritas Investment Partners’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.95K	Hold	1,809	–	–	﹤0.01%	2933
2025 Q4	$6.71K	Hold	1,809	–	–	﹤0.01%	2991
2025 Q3	$25.5K	Hold	1,809	–	–	﹤0.01%	2557
2025 Q2	$34.8K	Buy	+1,809	New	+$28.2K	﹤0.01%	2395
2024 Q2	–	Sell	-327	Closed	-$10.9K	–	3200
2024 Q1	$10.9K	Hold	327	–	–	﹤0.01%	2794
2023 Q4	$26.6K	Hold	327	–	–	﹤0.01%	2457
2023 Q3	$53.4K	Buy	327 +55	+20%	+$13K	﹤0.01%	2065
2023 Q2	$89.3K	Buy	272 +33	+14%	+$10.1K	﹤0.01%	1675
2023 Q1	$66K	Hold	239	–	–	﹤0.01%	1804
2022 Q4	$97.6K	Hold	239	–	–	﹤0.01%	1617
2022 Q3	$57K	Hold	239	–	–	﹤0.01%	1881
2022 Q2	$53K	Hold	239	–	–	﹤0.01%	1953
2022 Q1	$163K	Hold	239	–	–	0.01%	1309
2021 Q4	$165K	Hold	239	–	–	0.01%	1354
2021 Q3	$177K	Hold	239	–	–	0.01%	1305
2021 Q2	$179K	Buy	239 +183	+327%	+$140K	0.01%	1330
2021 Q1	$45K	Hold	56	–	–	﹤0.01%	2145
2020 Q4	$47K	Buy	+56	New	+$43.2K	﹤0.01%	2023

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ameritas Investment Partners's OM Position: Q1 2026 in Review

Ameritas Investment Partners held its Outset Medical (OM) position steady in Q1 2026 at 1,809 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #2933.

Ameritas Investment Partners first reported a position in OM in Q4 2020 and has held it in 18 quarters since. The position peaked at $179K in Q2 2021. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

Ameritas Investment Partners held 1,809 shares of Outset Medical worth $6.95K as of Q1 2026.
Ameritas Investment Partners left its Outset Medical share count unchanged in Q1 2026.
Outset Medical made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2933 holding.
Ameritas Investment Partners first reported a position in Outset Medical in Q4 2020 and has held it in 18 quarters since.
Ameritas Investment Partners's Outset Medical position peaked at $179K in Q2 2021.
99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.